RecruitingNot ApplicableNCT06949644

Pupillometry in Delayed Sleep Wake Phase Disorder

Pupillometry in DSWPD Type 1 and Type 2


Sponsor

Northwestern University

Enrollment

220 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this observational study is to characterize the pupil light response in patients with delayed sleep-wake phase disorder. A subset of participants will take part in a clinical trial to determine if increasing serotonin can alter the circadian response to light. The main questions it aims to answer is: Are there differences in the light response in patients with delayed sleep-wake phase disorder? Does citalopram increase melatonin suppression in patients with delayed sleep-wake phase disorder? Participants will complete activity and melatonin testing at home to determine their circadian timing. This will be followed by an eye test looking at the pupil response to different light stimuli. A subset of participants will complete two inpatient admissions where melatonin levels will be sampled and they will be exposed to a bright light. During one round of testing they will receive a placebo and in the other round of testing they will take a single dose of citalopram, a selective serotonin reuptake inhibitor.


Eligibility

Min Age: 16 Years

Inclusion Criteria1

  • Delayed sleep-wake phase disorder

Exclusion Criteria5

  • Use of medications known to alter pupil diameter
  • History of eye disease or eye surgery
  • Unstable medical or psychiatric condition
  • Shift work or self imposed irregular sleep schedules
  • Caffeine consumption >400mg/day

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTLight and Citalopram

Participants will receive placebo or citalopram, followed by bright light exposure


Locations(1)

Northwestern University

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06949644


Related Trials